Incidence of Pneumocystis Pneumonia in Immunocompromised Patients without Human Immunodeficiency Virus on Intravenous Pentamidine Prophylaxis: A Systematic Review and Meta-Analysis

Background: Trimethoprim-sulfamethoxazole (TMP-SMX) is a first-line Pneumocystis pneumonia (PCP) prophylaxis agent, but monthly intravenous pentamidine (IVP) is used in immunocompromised hosts without human immunodeficiency virus (HIV) infection because IVP is not associated with cytopenia and delay...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Chia-Yu, Ching, Patrick R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144649/
https://www.ncbi.nlm.nih.gov/pubmed/37108861
http://dx.doi.org/10.3390/jof9040406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144649/
https://www.ncbi.nlm.nih.gov/pubmed/37108861
http://dx.doi.org/10.3390/jof9040406

Ejemplares similares